Trial Profile

Immunogenicity and Safety of a DTwP-HepB-Hib-IPV (Shan6) Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Thailand

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hib-DTP-hepatitis B-poliovirus vaccine (Primary) ; Hib-DTP-hepatitis B vaccine; Pneumococcal 13-valent CRM197 vaccine conjugate; Poliovirus vaccine inactivated; Poliovirus vaccine live oral; RIX 4414
Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Pneumococcal infections; Poliomyelitis; Rotavirus infections; Tetanus
Focus Pharmacodynamics; Registrational
Sponsors Sanofi Pasteur

Most Recent Events

29 May 2023 Results published in the Pediatric Infectious Disease Journal
03 May 2022 Status changed from active, no longer recruiting to completed.
12 Apr 2021 Planned End Date changed from 1 Nov 2021 to 27 Oct 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com